Editor - Maciej J. Danilewicz | North Lakeside Medical Ltd. | 22219
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Maciej J. Danilewicz

Maciej J. Danilewicz
Maciej Jozef Danilewicz
Consultant Psychiatrist at Hesley Group
North Lakeside Medical Ltd.
United Kingdom


Dr. Maciej J. Danilewicz graduated in Medicine from Jagiellonian University in Krakow, Poland in 1997, where he subsequently became a Medical Lecturer. Upon relocating to the United Kingdom, he worked at substance misuse rehabilitation units in the independent sector, a medium secure forensic hospital, low secure forensic unit, a locked rehabilitation unit, a Substance Intervention Team Prison Service and the largest in the UK Addiction Treatment Initiative. He graduated in Cognitive Therapy studies from Oxford University in 2010 and Psychiatry studies from Cardiff University in 2013. Currently, he is a Consultant Psychiatrist at Hesley Group, and an Associate Specialist at CGL Group (former CRI Group) an addiction specialist service. Amongst his special interests is the recognition, management and treatment of substance misuse amongst patients suffering from major mental illness and development and efficacy assessment of the services. Dr. Danilewicz has a vast experience in creation, running, and assessing efficacy of the services which he exercised being the Responsible Officer for Glen Care Group and Choice Lifestyles Group. He also held the position of a Caldicott Guardian for the Choice Lifestyles Group being an advisory body to the CEO in regards to data confidentiality.

Research Interest

1. Abuse of prescribed medication in community and prison setting;
2. Efficacy of dexamphetamine in treatment of cocaine and amphetamine addiction;
3. Problems with engagement with the addiction treatment services – efficacy of methods and protocols; 4. Novel psychoactive substances – seriousness of the problem.